Enterovirus A71 antivirals: Past, present, and future.
Enterovirus A71 antivirals: Past, present, and future.
复制标题
DOI:
10.1016/j.apsb.2021.08.017
复制
发表时间:
2022-04
影响因子:
14.5
通讯作者:
Zheng, Madeleine
中科院分区:
文献类型:
--
作者:
Wang, Jun;Hu, Yanmei;Zheng, Madeleine
关键词:
Enterovirus A71 (EV-A71) is a significant human pathogen, especially in children. EV-A71 infection is one of the leading causes of hand, foot, and mouth diseases (HFMD), and can lead to neurological complications such as acute flaccid myelitis (AFM) in severe cases. Although three EV-A71 vaccines are available in China, they are not broadly protective and have reduced efficacy against emerging strains. There is currently no approved antiviral for EV-A71. Significant progress has been made in developing antivirals against EV-A71 by targeting both viral proteins and host factors. However, viral capsid inhibitors and protease inhibitors failed in clinical trials of human rhinovirus infection due to limited efficacy or side effects. This review discusses major discoveries in EV-A71 antiviral development, analyzes the advantages and limitations of each drug target, and highlights the knowledge gaps that need to be addressed to advance the field forward. The EV-A71 replication cycle provides multiple targets for drug design, and the promising ones include the capsid protein, the 2A and 3C proteases, 2C protein, and the 3D polymerase.
登录
查看更多内容
影响因子:
8
作者:
BASAVAPPA, R;SYED, R;HOGLE, JM
通讯作者:
HOGLE, JM
影响因子:
7.6
作者:
Albulescu, Lucian;Bigay, Joelle;Strating, Jeroen R. P. M.
通讯作者:
Strating, Jeroen R. P. M.
影响因子:
5.2
作者:
Chang CS;Liao CC;Liou AT;Chou YC;Yu YY;Lin CY;Lin JS;Suen CS;Hwang MJ;Shih C
通讯作者:
Shih C
影响因子:
14.8
作者:
Burgett, Anthony W. G.;Poulsen, Thomas B.;Wangkanont, Kittikhun;Anderson, D. Ryan;Kikuchi, Chikako;Shimada, Kousei;Okubo, Shuichi;Fortner, Kevin C.;Mimaki, Yoshihiro;Kuroda, Minpei;Murphy, Jason P.;Schwalb, David J.;Petrella, Eugene C.;Cornella-Taracido, Ivan;Schirle, Markus;Tallarico, John A.;Shair, Matthew D.
通讯作者:
Shair, Matthew D.
影响因子:
11
作者:
Anasir MI;Zarif F;Poh CL
通讯作者:
Poh CL